Allerderm Efa-Z Plus 58 mg / 8 mL Solution is a Health Canada–registered veterinary drug (DIN 02336014) held by Virbac Ah, Inc., containing Eicosapentaenoic Acid. Health Canada lists its status as Cancelled Post Market (status date 26 Apr 2018). Nexara Health has matched 4 registrations of Eicosapentaenoic Acid across 2 other regulated markets.
Health Canada registration
| DIN | 02336014 |
|---|---|
| Brand name | Allerderm Efa-Z Plus |
| Active ingredient | Eicosapentaenoic Acid |
| Strength | 58 mg / 8 mL |
| Dosage form | Solution |
| Route | Oral |
| Company | Virbac Ah, Inc. |
| Status | Cancelled Post Market — 26 Apr 2018 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Eicosapentaenoic Acid registered in other markets
4 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Greece | LOITROL ORAL.SOL (791+527)MG/5ML BTx1 BOTTLEx150 ML | Rafarm A.e.b.e. | non-reimbursed | MoH deltio timwn | ||
| United Kingdom | Eicosapentaenoic acid 170mg / Docosahexaenoic acid 115mg capsules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Eicosapentaenoic acid 170mg/g / Docosahexaenoic acid 115mg/g oral liquid | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Eicosapentaenoic acid 460mg / Docosahexaenoic acid 380mg capsules | — | 0001 | NHS dm+d VMP |
See every manufacturer of Eicosapentaenoic Acid worldwide →
Regulator price references for Eicosapentaenoic Acid
Published list or reimbursement prices for Eicosapentaenoic Acid presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Greece | LOITROL ORAL.SOL (791+527)MG/5ML BTx1 BOTTLEx150 ML | 150ml+5ml | 13.22 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Allerderm Efa-Z Plus (DIN 02336014) marketed in Canada?
No. Health Canada lists DIN 02336014 as Cancelled Post Market as of 26 Apr 2018.
Who holds the Canadian licence for this product?
Virbac Ah, Inc. is the company of record in the Health Canada Drug Product Database.
Is Eicosapentaenoic Acid registered outside Canada?
Yes — Nexara Health has matched 4 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02336014, status date 2018-04-26; national medicine registries: MoH deltio timwn, NHS dm+d VMP; price sources: MoH deltio timwn. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02336014, status date 2018-04-26; national medicine registries: MoH deltio timwn, NHS dm+d VMP; price sources: MoH deltio timwn.
Health Canada Drug Product Database (DPD), DIN 02336014, status date 2018-04-26; national medicine registries: MoH deltio timwn, NHS dm+d VMP; price sources: MoH deltio timwn. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.